Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded up 18.4% during mid-day trading on Monday . The company traded as high as GBX 1.80 ($0.02) and last traded at GBX 1.80 ($0.02). 1,461,598 shares were traded during trading, an increase of 19% from the average session volume of 1,225,284 shares. The stock had previously closed at GBX 1.52 ($0.02).
Cizzle Biotechnology Stock Performance
The stock’s 50-day moving average price is GBX 1.79 and its 200-day moving average price is GBX 1.85. The company has a market capitalization of £7.09 million, a price-to-earnings ratio of -2,511.86 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- What is diluted earnings per share (Diluted EPS)?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 ETFs to Ride the VIX Surge During Market Volatility
- 3 Best Fintech Stocks for a Portfolio Boost
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
